ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,615,595 | +932.0% | 501,680 | +1270.1% | 0.08% | +1014.3% |
| Q2 2023 | $1,319,310 | 0.0% | 36,617 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,319,310 | -6.3% | 36,617 | +2.7% | 0.01% | -12.5% |
| Q4 2022 | $1,408,729 | +16.0% | 35,646 | +17.9% | 0.01% | 0.0% |
| Q3 2022 | $1,214,000 | +75.7% | 30,236 | +70.2% | 0.01% | +166.7% |
| Q1 2022 | $691,000 | -9.3% | 17,761 | -15.9% | 0.00% | -25.0% |
| Q3 2021 | $762,000 | -16.8% | 21,108 | -5.6% | 0.00% | -20.0% |
| Q2 2021 | $916,000 | -29.7% | 22,366 | -25.1% | 0.01% | -28.6% |
| Q1 2021 | $1,303,000 | +16.4% | 29,878 | +33.6% | 0.01% | +16.7% |
| Q4 2020 | $1,119,000 | – | 22,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |